The Foundation for Metabolic Cancer Therapies has awarded a research grant to Dr. Peter Pedersen at John Hopkins School of Medicine. The research will focus on screening for Hexokinase 2 inhibitors. Hexokinase 2 represents one of the most promising metabolic targets within the cancer cell. Dr. Pedersen is an outstanding biochemical researcher with an extraordinary track record, and we are proud […]
We have decided to change the name of our foundation from The Single Cause Single Cure Foundation, to The Foundation for Metabolic Cancer Therapies. We think this name better reflects our ethos. It was pointed out that perhaps Single Cause Single Cure could be interpreted as encouraging patients to seek a single cure. That is not the case. Research has […]
This article on the use of the ketogenic diet for gliomas was featured in the July issue of Cure.
This important publication documents the full remission of a patient with stage 4, triple negative breast cancer. The protocol was designed and refined at Chemothermia Oncology Center in Istanbul Turkey. Dr. Slocum and his colleagues were inspired by the research of Dr. Seyfried and others, and are pioneers in the implementation of metabolic therapies.
In May of 2016 we awarded a substantial grant to Dr. Thomas Seyfried’s lab at Boston College. The grant is funding the exploration of a cocktail of metabolic therapies in a metastatic mouse model. The experiment will test the combination of the ketogenic diet, glycolytic inhibitors, oxygen therapy, glutamine inhibitors, exogenous ketones, and other metabolic […]
The Foundation for Metabolic Cancer Therapies has funded a remarkable study combining oxaloacetate with various metabolic therapies. The results were so compelling that a larger and more comprehensive study was commissioned and is currently underway. We will present the results as soon as we possibly can. On another front, SCSC is in talks to fund a […]
I was recently talking to a friend of mine about the post-treatment anxiety felt by most cancer patients when their mind inevitably circles to the question: “Is my cancer still there, lingering, just waiting to come back?” My friend also happens to be a cancer researcher with a doctorate from MIT, and a cancer survivor. […]
Hello, this is Travis Christofferson the founder of SCSC. For the last year I have “gone dark” while I wrote a book about the metabolic theory of cancer. Its finished — I’ve reemerged — and its very nice to be back. It will be for sale on Amazon in about 10 days. The book explores the history, and […]
The striking feature of cancer therapy once cancer is framed as a metabolic disease is the combinatorial synergy observed. We have observed the synergistic efficacy when the ketogenic diet is combined with radiation, cisplatin, 2DG, and now hyperbaric oxygen therapy. Here is a link to the study.